Herbal supplement (Combi-5) in the management of COVID 19 individual with mild to moderate symptoms: a case report

Augustine Anayochukwu Onyeaghala; Emmanuella Ogechi Onyeaghala; Chinedum Peace Babalola; Oluwasanmi Olayinka Aina; Dadik Jelpe

doi:10.1515/jcim-2020-0430

Herbal supplement (Combi-5) in the management of COVID 19 individual with mild to moderate symptoms: a case report

J Complement Integr Med. 2021 May 10;18(4):865-867. doi: 10.1515/jcim-2020-0430.

Authors

Augustine Anayochukwu Onyeaghala^{1

2}, Emmanuella Ogechi Onyeaghala³, Chinedum Peace Babalola^{4

5

6}, Oluwasanmi Olayinka Aina⁷, Dadik Jelpe⁸

Affiliations

¹ Unit of Clinical Chemistry, Department of Medical Laboratory Science, University College Hospital, Ibadan, Nigeria.
² Unit of Clinical Chemistry, Department of Medical Laboratory Science, Lead City University, Ibadan, Nigeria.
³ Department of Medical Laboratory Science, Achievers University, Owo, Ondo State, Nigeria.
⁴ Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria.
⁵ Centre for Drug Discovery Development and Production (CDDDP), University of Ibadan, Ibadan, Nigeria.
⁶ College of Basic Medical Sciences, Chrisland University, Abeokuta, Nigeria.
⁷ Department of Veterinary Anatomy, University of Ibadan, Ibadan, Nigeria.
⁸ Plateau State Specialist Hospital, Jos, Plateau State, Nigeria.

PMID: 33962499
DOI: 10.1515/jcim-2020-0430

Abstract

Objective: To explore repurposing known natural products for managing patients with mild to moderate symptoms of COVID-19.

Case presentation: We present a case report of a middle aged woman, who was positive to COVID 19, with mild to moderate symptoms; who self -managed at home using well formulated herbal supplement (Combi-5) taken along with vitamin C and Zinc supplements. She recovered within a short time.

Conclusions: While we may not conclude from this report that Combi-5 was solely responsible for the recovery of the patient, we strongly believe that it played significant role through different mechanisms in facilitating early recovery from the infection. Further studies are needed to evaluate the phytochemical and pharmacological constituents of the supplement; investigate its direct effect(s) on SARS CoV-2 and conduct randomized controlled trial to elucidate its clinical benefits.

Keywords: COVID 19; Combi-5; SARS CoV-2.

Publication types

Case Reports

MeSH terms

COVID-19*
Dietary Supplements
Female
Humans
Middle Aged
SARS-CoV-2
Vitamins

Substances

Vitamins